Emyria Ltd (AU:EMD) has released an update.
Emyria Ltd, a company focused on novel mental health and neurological treatments, has announced the strategic appointment of Mr Simon Kemp as General Manager of Clinical Operations. Kemp, with a history of success in the health sector including the expansion of Sleep Studies Australia, is expected to bolster Emyria’s clinical services and patient care. Concurrently, the firm acknowledged the resignation of CFO Mr Joseph Ohayon and has implemented interim measures to cover his duties.
For further insights into AU:EMD stock, check out TipRanks’ Stock Analysis page.